It has been evaluated in multiple Phase 3 randomized controlled trials, meta-analyses, and a Cochrane systematic review across indications including Alzheimer's disease, vascular dementia, and stroke
Its application to deeper knee structures such as the joint capsule, ligaments, or cartilage in human patients remains largely theoretical at this stage
The combination of human-identical peptides plus protective delivery results in molecules that can influence localized tissue repair, modulate immune signaling to reduce inflammation, support mitochondrial NAD+ pathways for energy via NMN, or encourage collagen synthesis for skin improvement, which together explain the breadth of benefits people report when they use these targeted protocols consistently
Patients commonly report improved endurance, better fat metabolism, and increased stamina even during normal daily routines